66.1

James Bartley

Loma Linda University Children's Hospital

Researcher James Bartley has made significant contributions to the fields of genetics, molecular biology, and medical research. Their recent studies have identified de novo variants in FRMD5, CNOT1, and other genes associated with neurodevelopmental delay, intellectual disability, ataxia, and abnormalities of eye movement. Additionally, they have explored the effects of urea cycle disorders on patients' health, including hyperammonemic crises, and developed biomarkers such as urinary phenylacetylglutamine concentration to monitor treatment adherence. Furthermore, Bartley's research has expanded into evolutionary biology, studying the role of microorganisms in driving evolution, and speech characteristics in children with velocardiofacial syndrome. These findings have important implications for understanding genetic disorders, developing effective treatments, and shedding light on the complex relationships between humans and their environment.

Speech OutcomesInborn Errors of Metabolism
Firms applying this knowledge

Horizon Therapeutics, Llc, Synlogic Operating Company, Inc.

Commercial signal 65.6
Scientific signal 69.8
Social signal 66.7
Papers 17
77 Patent-to-paper cites
459 Paper cites

scientifiq.ai is an experimental platform. The platform relies on open source data and it may contain errors. Its primary goal is to advance scientific research on innovation.